CELLPROTHERA Trademark

Trademark Overview


On Wednesday, April 1, 2020, a trademark application was filed for CELLPROTHERA with the United States Patent and Trademark Office. The USPTO has given the CELLPROTHERA trademark a serial number of 79284565. The federal status of this trademark filing is REGISTERED as of Tuesday, November 23, 2021. This trademark is owned by CELLPROTHERA. The CELLPROTHERA trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Biological preparations for cell cultures, cell culture media, culture media for cell growth for medical biotechnology, biological reagents for molecular biology, chemical reagents for medical use for biological processes, carriers of culture media for medical use, cellular function activating agents, serums, antibodies, all these products being for medical use

Services for medical care and treatment, namely therapeutic treatments in the field of cell therapy and regenerative medicine; medical services for cell growth, sampling and isolation for the production of cell and cell-derived human and animal cell products, namely, cell and stem cell graft injection therapy allowing for the regeneration of damaged tissues following age-related diseases or traumas for medical treatment services; services for medical analysis relating to treating individuals, namely, behavioral analysis for medical purposes, therapeutic treatment, namely cell therapy for regenerative medicine

Medical apparatus and instruments, namely, medical devices in the nature of human and animal cell, stem cells and cell-derived products and instruments for injection of cell, stem cells and cell-derived products, namely, chambers for culture, centrifugation and isolation of cell, stem cell and cell-derived for cell-based diagnosis and treatment; apparatus for cell culture, namely medical devices for human and animal cell culture diagnosis and treatment; medical instruments for cell culture, namely instruments for cell culture media and for potency testing of human and animal cell and cell-derived products for cell based treatment and diagnostic; medical apparatus and devices for cell separation techniques, namely, medical device and apparatus for human and animal cell selection, for human cell immune and for cell dimension selection for the cell-based diagnosis and treatment

Research and development services of new products in the field of biotechnology, scientific analysis services in the field of medical research laboratory services for medical purposes and for development of new products for medical research for third parties
cellprothera

General Information


Serial Number79284565
Word MarkCELLPROTHERA
Filing DateWednesday, April 1, 2020
Status700 - REGISTERED
Status DateTuesday, November 23, 2021
Registration Number6564631
Registration DateTuesday, November 23, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized wording "CELLPROTHERA" and the letter "O" is completely shaded.
Goods and ServicesBiological preparations for cell cultures, cell culture media, culture media for cell growth for medical biotechnology, biological reagents for molecular biology, chemical reagents for medical use for biological processes, carriers of culture media for medical use, cellular function activating agents, serums, antibodies, all these products being for medical use
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "CELLPROTHERA" has no meaning in a foreign language.
Goods and ServicesServices for medical care and treatment, namely therapeutic treatments in the field of cell therapy and regenerative medicine; medical services for cell growth, sampling and isolation for the production of cell and cell-derived human and animal cell products, namely, cell and stem cell graft injection therapy allowing for the regeneration of damaged tissues following age-related diseases or traumas for medical treatment services; services for medical analysis relating to treating individuals, namely, behavioral analysis for medical purposes, therapeutic treatment, namely cell therapy for regenerative medicine
Goods and ServicesMedical apparatus and instruments, namely, medical devices in the nature of human and animal cell, stem cells and cell-derived products and instruments for injection of cell, stem cells and cell-derived products, namely, chambers for culture, centrifugation and isolation of cell, stem cell and cell-derived for cell-based diagnosis and treatment; apparatus for cell culture, namely medical devices for human and animal cell culture diagnosis and treatment; medical instruments for cell culture, namely instruments for cell culture media and for potency testing of human and animal cell and cell-derived products for cell based treatment and diagnostic; medical apparatus and devices for cell separation techniques, namely, medical device and apparatus for human and animal cell selection, for human cell immune and for cell dimension selection for the cell-based diagnosis and treatment
Goods and ServicesResearch and development services of new products in the field of biotechnology, scientific analysis services in the field of medical research laboratory services for medical purposes and for development of new products for medical research for third parties

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, May 3, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 3, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 3, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCELLPROTHERA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameCELLPROTHERA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameCELLPROTHERA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Monday, May 30, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, May 10, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 10, 2022FINAL DISPOSITION PROCESSED
Wednesday, February 23, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 23, 2021REGISTERED-PRINCIPAL REGISTER
Friday, October 29, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 6, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 6, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Saturday, September 4, 2021NOTIFICATION PROCESSED BY IB
Wednesday, August 18, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 18, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 21, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 8, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 8, 2021FINAL REFUSAL E-MAILED
Monday, March 8, 2021FINAL REFUSAL WRITTEN
Wednesday, January 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 29, 2020REFUSAL PROCESSED BY IB
Tuesday, August 4, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 4, 2020REFUSAL PROCESSED BY MPU
Monday, June 29, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, June 28, 2020NON-FINAL ACTION WRITTEN
Sunday, June 21, 2020ASSIGNED TO EXAMINER
Thursday, May 7, 2020APPLICATION FILING RECEIPT MAILED
Sunday, May 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 30, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB